Comprehensive MR imaging protocol for stroke management: Tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies

Radiology

Volumn 213, Issue 1, 1999, Pages 156-166

  Thulborn, Keith R ^a   Gindin, Tatyana S ^a   Davis, Denise ^a   Erb, Patricia ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Brain, infarction; Brain, MR; Magnetic resonance (MR), diffusion study; Magnetic resonance (MR), perfusion study; Magnetic resonance (MR), sodium studies; Thrombolysis

Indexed keywords

ANIMAL MODEL; ARTICLE; BRAIN PERFUSION; CELL VIABILITY; CLINICAL PROTOCOL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FIBRINOLYTIC THERAPY; MACACA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SODIUM CELL LEVEL; STROKE;

EID: 0032887073     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.213.1.r99se15156     Document Type: Article

References (69)

1. Bonita R. Epidemiology of stroke. Lancet 1992; 339:342-344.
2. Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke 1989; 20:577-582.
3. Malmgren R, Bamford J, Warlow C, Sandercock P, Slattery J. Projecting the number of patients with first ever strokes and patients newly handicapped by stroke in England and Wales. BMJ 1989; 298:656-660.
4. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27:373-380.
5. Barinaga M. Finding new drugs to treat stroke. Science 1996; 272:664-666.
6. Marder VJ, Sherry S. Thrombolytic therapy. I. Current status. N Engl J Med 1988; 318:1512-1520.
7. Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: correlations of outcome with clinical and radiological data. Stroke 1996; 27:882-890.
8. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
9. Trust Study Group. Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 1990; 336: 1205-1209.
10. Barnett HJ. The contribution of multicenter trials to stroke prevention and treatment. Arch Neurol 1990; 47:441-444.
11. Marsh EE III, Adams HP Jr, Biller J, et al. Use of antithrombotic drugs in the treatment of acute ischemic stroke: a survey of neurologists in practice in the United States. Neurology 1989; 39:1631-1634.
12. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36:557-565.
13. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds and the therapeutic window for acute stroke. Ann Neurol 1994; 36:553-554.
14. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981; 12:723-725.
15. DeGirolami U, Crowell RM, Marcoux FW. Selective necrosis and total necrosis in focal cerebral ischemia: neuropathologic observations on experimental middle cerebral artery occlusion in the macaque monkey. J Neuropathol Exp Neurol 1984; 43:57-71.
16. Hossmann KA, Schuier FJ. Experimental brain infarcts in cats. I. Pathophysiological observations. Stroke 1980; 11:583-592.
17. Pulsinelli W. Pathophysiology of acute ischeamic stroke. Lancet 1992; 339:533-536.
18. Berendsen HJC, Edzes HT. The observation and general interpretation of sodium magnetic resonance in biological material. Ann N Y Acad Sci 1973; 204:459-485.
19. Hilal SK, Maudsley AA, Simon, HE, et al. In vivo NMR imaging of tissue sodium in the intact cat before and after acute cerebral stroke. AJNR 1983; 4:245-249.
20. Hilal SK, Maudsley AA, Ra JB, et al. In vivo NMR imaging of sodium-23 in the human head. J Comput Assist Tomogr 1985; 9:1-7.
21. Perman WH, Turski PA, Houston LW, Glover GH, Hayes CE. Methodology of in vivo human sodium imaging at 1.5 T. Radiology 1986; 160:811-820.
22. Moonen CT, Anderson SE, Unger S. 23Na rotating frame imaging in the perfused rabbit heart using separate transmitter and receiver coils. Magn Reson Med 1987; 5:296-301.
23. Ra JB, Hilal SK, Oh CH, Mun IK. In vivo magnetic resonance imaging of sodium in the human body. Magn Reson Med 1988; 7:11-22.
24. Perman WH, Thomasson DM, Bernstein MA, Turski PA. Multiple short-echo (2.5-ms) quantitation of in vivo sodium T2 relaxation. Magn Reson Med 1989; 9:153-160.
25. Winkler SS, Thomasson DM, Sherwood K, Perman WH. Regional T2 and sodium concentration estimates in the normal human brain by sodium-23 MR imaging at 1.5 T. J Comput Assist Tomogr 1989; 13:561-566.
26. Hilal SK, Ra JB, Oh CH, Mun IK, Einstein SG, Roschmann P. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging. St Louis, Mo: Mosby, 1990; 715-731.
27. Boada FB, Gillen JS, Shen GX, Chang SY, Thulborn KR. Fast three dimensional sodium imaging. Magn Reson Med 1997; 37:706-715.
28. Shen GX, Boada FE, Thulborn KR. Dual-frequency, dual-quadrature, birdcage RF coil design with identical B1 pattern for sodium and proton imaging of the human brain at 1.5 T. Magn Reson Med 1997; 38:717-725.
29. Rooney WD, Springer CS Jr. A comprehensive approach to the analysis and interpretation of the resonances of spins 3/2 from living systems. NMR Biomed 1991; 4:209-226.
30. Rooney WD, Springer CS Jr. The molecular environment of intracellular sodium: 23Na NMR relaxation. NMR Biomed 1991; 4:227-245.
31. Boada FE, Christensen JD, Huang-Hellinger FR, Reese TG, Thulborn KR. Quantitative in vivo sodium concentration maps: the effects of biexponential relaxation. Magn Reson Med 1994; 32: 219-223.
32. 1, a scheme for analysis of in vivo metabolites. J Magn Reson 1983; 55:357-371.
33. Christensen JD, Barrère BJ, Boada FE, Vevea JM, Thulborn KR. Quantitative tissue sodium concentration mapping of normal rat brain. Magn Reson Med 1996; 36:83-89.
34. Hees P, Christensen JD, Boada FE, Thulborn KR. Assessment of stroke by functional MRI techniques (abstr). In: Proceedings of 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993; 1399.
35. Thulborn KR, Uttecht S, Betancourt C, Talagala SL, Boada FE, Shen GX. A functional, physiological and metabolic tool-box for clinical magnetic resonance imaging: integration of acquisition and analysis strategies. Int J Imaging Syst Technol 1997; 8:572-581.
36. Thulborn KR, Davis D, Erb P, Strojwas M, Sweeney JA. Clinical fMRI: implementation and experience. Neuroimage 1996; 4 (suppl):101-107.
37. Thulborn KR, Voyvodic J, Chang S, Strojwas M, Sweeney JA. New approaches to cognitive function by high field functional MRI. In: Yuasa T, Prichard JW, Ogawa F, eds. Current progress in functional brain mapping. London, England: Smith-Gordon, 1998; 15-23.
38. Thulborn KR, Gillen JS, McCurtain B, Betancourt C, Sweeney JA. Functional magnetic resonance imaging of the human brain. Bull Magn Reson 1996; 18:37-42.
39. Shen GX, Wu JF, Boada FE, Thulborn KR. Experimentally verified theoretical design of dual-tuned, low-pass birdcage radiofrequency resonators for magnetic resonance imaging and magnetic resonance spectroscopy of human brain at 3.0 Tesla. Magn Reson Med 1999; 41:268-275.
40. Boada FE, Shen GX, Chang SY, Thulborn KR. Spectrally weighted twisted projection imaging: reducing T2 signal attenuation effects in fast three-dimensional sodium imaging. Magn Reson Med 1997; 38:1022-1028.
41. Chesler D, Vevea JM, Boada FE, Thulborn KR. Rapid 3-D reconstruction from 1-D projections for metabolic MR imaging of short T2 species (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1992. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1992; 665.
42. Thulborn KR, Boada FE, Shen GX, Christensen JD, Reese TG. Correction of B1 inhomogeneities using echo-planar imaging of water. Magn Reson Med 1998; 39:369-375.
43. Beauchamp NJ Jr, Ulug AM, Passe TJ, van Zijl PC. MR diffusion imaging in stroke: review and controversies. RadioGraphics 1998; 18:1269-1283.
44. Nicholson C, Sykova E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci 1998; 21:207-215.
45. Kertesz A, Black SE, Nicholson L, Carr T. The sensitivity and specificity of MRI in stroke. Neurology 1987; 37:1580-1585.
46. Bose B, Jones SC, Lorig R, Friel HT, Weinstein M, Little JR. Evolving focal cerebral ischemia in cats: a spatial correlation of nuclear magnetic resonance imaging, cerebral blood flow, tetrazolium staining and histopathology. Stroke 1988; 19:28-37.
47. Yuh WT, Crain MR, Loes DJ, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: findings in the first 24 hours. AJNR 1991; 12:621-629.
48. Back T, Hoehn-Berlage M, Kohno K, Hossmann KA. Diffusion nuclear magnetic resonance imaging in experimental stroke: correlation with cerebral metabolites. Stroke 1994; 25:494-500.
49. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR 1990; 11:423-429.
50. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990; 14:330-346.
51. Chien D, Buxton RB, Kwong KK, Brady TJ, Rosen BR. MR diffusion imaging of the human brain. J Comput Assist Tomogr 1990; 14:514-520.
52. Knight RA, Ordidge RJ, Helpern JA, Chopp M, Rodolosi LC, Peck D. Temporal evolution of ischemic damage in rat brain measured by proton nuclear magnetic resonance imaging. Stroke 1991; 22:802-808.
53. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 1992; 42:235-240.
54. de Crespigny AJ, Tsuura M, Moseley ME, Kucharczyk J. Perfusion and diffusion MR imaging of thromboembolic stroke. JMRI 1993; 3:746-754.
55. Warach S, Wielopolski P, Edelman R. Identification and characterization of the ischemic penumbra of acute human stroke using echo planar diffusion and perfusion imaging (abstr). In: Proceedings of the 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993: 249.
56. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6:164-174.
57. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989; 5:263-281.
58. Kucharczyk J, Asgari H, Mintorovitch J, et al. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA in normal and ischemic cat brain. AJNR 1993; 14:289-296.
59. Maeda M, Itoh S, Ide H, et al. Acute stroke in cats: comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging. Radiology 1993; 189:227-232.
60. Hamberg L, Huang Z, Hunter G, Caramia F, Moskowitz M, Rosen BR. Time effects of L-arginine on cerebral hemodynamics and ischemic volume during acute focal ischemia demonstrated by dynamic MRI (abstr). In: Proceedings of the 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993: 397.
61. Caramia F, Yoshida T, Huany Z, et al. Measurement of cerebrovascular changes in rats following L-arginine infusion using dynamic magnetic resonance imaging (abstr). In: Proceedings of the 12th Annual Scientific Meeting of the Society of Magnetic Resonance in Medicine. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993; 1385.
62. Sorenson AG, Koroshetz WJ, Schwamm L, et al. Diffusion/perfusion mismatch in MRI of acute human stroke (abstr). In: Proceedings of the Fourth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1996: 91.
63. Cohen MS, Weisskoff RM. Ultra-fast imaging. Magn Reson Imaging 1991; 9:1-37.
64. McKinstry RC, Weisskoff RM, Belliveau JW, et al. Ultrafast MR imaging of water mobility: animal models of altered cerebral perfusion. JMRI 1992; 2:377-384.
65. Hamberg LM, Boccalini P, Stranjalis G, et al. Continuous assessment of relative cerebral blood volume in transient ischemia using steady state susceptibility-contrast MRI. Magn Reson Med 1996; 35:168-173.
66. Levin JM, Kaufman MJ, Ross MH, et al. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 1995; 34:655-663.
67. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurements of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993; 29:553-558.
68. Pulsinelli WA, Jacewicz M. Animal models of brain ischemia. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: pathophysiology, diagnosis and management. 2nd ed. New York, NY: Churchill Livingstone, 1992; 49-68.
69. Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54:773-782.